Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BELISS: Belimumab in Primary Sjögren's Syndrome
NCT01008982Phase 2Completed
- Sponsor
- University of Udine
- Start
- Aug 2009
- Primary completion
- Aug 2012
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of belimumab in primary Sjögren's syndrome, sponsored by University of Udine. Started Aug 2009; status: completed.
02
Drugs
belimumab
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on NCT01008982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01008982.